Anti-PD-1 checkpoint blockade improves the efficacy of a melphalan-based therapy in experimental melanoma
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference38 articles.
1. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy;Pawlik;Ann Surg Oncol,2005
2. ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee;Michielin;Ann Oncol,2020
3. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma;Ribas;J Am Med Assoc,2016
4. Anti-PD-1 and PD-L1 antibodies in metastatic melanoma;Simeone;Melanoma Manag,2017
5. The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trials;Olofsson Bagge;Melanoma Res,2021
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment;European Journal of Surgical Oncology;2024-09
2. Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma;Annals of Surgical Oncology;2024-08-22
3. The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial);European Journal of Surgical Oncology;2024-06
4. Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liver;Clinical & Experimental Metastasis;2023-10-16
5. Upgrading Melanoma Treatment: Promising Immunotherapies Combinations in the Preclinical Mouse Model;Current Cancer Therapy Reviews;2023-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3